Orwin Says Affymax Entering $2 Billion Dialysis Market

416 views · Published 27 June 2011 · 2:44 · Indexed 30 October 2026

Channel: Bloomberg Originals · 2011 · Entertainment

Watch on YouTube

June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug pricing strategy.
     Orwin speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Street Smart." (Source: Bloomberg)

More from this channel